Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly and Co.
有很多钱可花费的鲸鱼已经明显看涨礼来。
Looking at options history for Eli Lilly and Co (NYSE:LLY) we detected 51 trades.
查看Eli Lilly and Co (纽交所:LLY)期权历史，我们检测到51笔交易。
If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 35% with bearish.
如果我们考虑每笔交易的具体情况，可以准确地说，41%的投资者看好，35%的投资者看淡。
From the overall spotted trades, 15 are puts, for a total amount of $787,764 and 36, calls, for a total amount of $2,008,387.
从整体发现的交易中，看跌期权共有15个，总金额为$ 787,764，而看涨期权共有36个，总金额为$ 2,008,387。
What's The Price Target?
目标价是多少？
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $300.0 to $1200.0 for Eli Lilly and Co over the last 3 months.
考虑到这些合约的成交量和持仓量，似乎鲸鱼一直在过去的三个月里将Eli Lilly and Co的价格区间定为$ 300.0至$ 1200.0。
Volume & Open Interest Development
成交量和持仓量的评估是期权交易中的一个关键步骤。这些指标揭示了阿里巴巴集团（Alibaba Gr Hldgs）特定执行价格期权的流动性和投资者兴趣。下面的数据可视化了在过去30天内，阿里巴巴集团（Alibaba Gr Hldgs）在执行价格在74.0美元到120.0美元区间内的看涨看跌期权中，成交量和持仓量的波动情况。
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Eli Lilly and Co's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Eli Lilly and Co's significant trades, within a strike price range of $300.0 to $1200.0, over the past month.
审查成交量和持仓量为股票研究提供了关键见解。这些信息在衡量Eli Lilly and Co在某些执行价格的期权的流动性和兴趣水平方面至关重要。下面，我们提供过去一个月内Eli Lilly and Co重大交易的看涨期权和看跌期权在$ 300.0至$ 1200.0行使价格区间内成交量和持仓量的趋势快照。
Eli Lilly and Co Option Volume And Open Interest Over Last 30 Days
Eli Lilly and Co过去30天期权成交量和持仓量
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | SWEEP | NEUTRAL | 09/20/24 | $105.65 | $103.4 | $104.48 | $730.00 | $313.3K | 101 | 30 |
| LLY | CALL | TRADE | BULLISH | 01/17/25 | $526.7 | $518.15 | $523.31 | $300.00 | $156.9K | 234 | 3 |
| LLY | PUT | SWEEP | BULLISH | 01/17/25 | $102.45 | $99.2 | $99.2 | $870.00 | $119.0K | 51 | 6 |
| LLY | PUT | TRADE | NEUTRAL | 08/02/24 | $105.2 | $97.95 | $100.93 | $910.00 | $111.0K | 146 | 11 |
| LLY | CALL | SWEEP | NEUTRAL | 08/02/24 | $17.1 | $16.65 | $17.1 | $810.00 | $100.5K | 127 | 191 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看涨 | SWEEP | 中立 | 09/20/24 | $105.65 | $103.4 | $104.48 | 730.00美元 | $313.3K | 101 | 30 |
| LLY | 看涨 | 交易 | 看好 | 01/17/25 | $526.7 | $518.15 | $523.31 | $ 300.00 | $156.9K | 234 | 3 |
| LLY | 看跌 | SWEEP | 看好 | 01/17/25 | $102.45 | $99.2 | $99.2 | $870.00 | $119.0K | 51 | 6 |
| LLY | 看跌 | 交易 | 中立 | 08/02/24 | $105.2 | $97.95 | $100.93 | $910.00 | $111.0K | 146 | 11 |
| LLY | 看涨 | SWEEP | 中立 | 08/02/24 | $17.1 | $16.65 | $17.1 | 810.00美元 | $100.5K | 127 | 191 |
About Eli Lilly and Co
关于礼来
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
礼来是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。礼来的主要产品包括用于癌症的维津尼奥；马天尼罗、泽普邦、贾达信、特鲁利康、胰岛素诺和人用胰岛素用于糖尿病；以及用于免疫学的塔吉特和优泰乐。
In light of the recent options history for Eli Lilly and Co, it's now appropriate to focus on the company itself. We aim to explore its current performance.
考虑到Eli Lilly and Co的最近期权历史，现在应该关注公司本身。我们的目标是探索其当前表现。
Where Is Eli Lilly and Co Standing Right Now?
礼来现在处于什么位置?
- With a trading volume of 774,075, the price of LLY is up by 1.56%, reaching $817.21.
- Current RSI values indicate that the stock is may be approaching oversold.
- Next earnings report is scheduled for 10 days from now.
- 成交量为774,075股，LLY股价上涨1.56%，达到817.21美元。
- 当前RSI值表明该股票可能即将超卖。
- 下一个盈利报告计划在10天内发布。
What Analysts Are Saying About Eli Lilly and Co
关于礼来，分析师们有何看法
In the last month, 5 experts released ratings on this stock with an average target price of $986.6.
在过去一个月里，有5位专家发布了对该股票的评级，平均目标价为986.6美元。
- Maintaining their stance, an analyst from Berenberg continues to hold a Buy rating for Eli Lilly and Co, targeting a price of $1000.
- Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Eli Lilly and Co, targeting a price of $1000.
- Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Eli Lilly and Co, targeting a price of $1025.
- Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for Eli Lilly and Co, targeting a price of $1023.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $885.
- 一位来自柏瑞银行的分析师维持对礼来的买入评级，并将目标价设定为1000美元。
- 一位来自JP Morgan的分析师维持对礼来的增持评级，并将目标价设定为1000美元。
- 一位来自巴克莱银行的分析师维持对礼来的增持评级，并将目标价设定为1025美元。
- 一位来自大摩资源lof的分析师维持对礼来的增持评级，并将目标价设定为1023美元。
- 来自Cantor Fitzgerald的分析师将其行动降级为Overweight，并设定了885美元的价格目标。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Eli Lilly and Co with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也可能带来更高的利润。精明的交易者通过持续的教育、策略性的交易调整、利用各种因子以及密切关注市场的动态来减轻这些风险。通过Benzinga Pro了解礼来公司的最新期权交易，获取实时提示。